Press Releases

Washington, D.C.—Today, Representatives Lloyd Doggett (D-TX-37), Rosa DeLauro (D-CT-03), and Senator Sheldon Whitehouse (D-RI) led 34 of their colleagues in urging Trade Ambassador Katherine Tai to proceed with reported plans to address ongoing harms attributable to investor-state dispute settlement (ISDS) mechanisms in U.S. free trade agreements. Specifically, the members call for the elimination, or drastic reduction, of the ability of powerful multinational corporations to use ISDS tribunals to extract unlimited sums from sovereign countries over laws, actions, or court rulings that allegedly conflict with corporate investments.

Washington, D.C.—Today, U.S. Representative Lloyd Doggett (D-Austin) released the following statement: “Yesterday, the FAA implemented another ground delay at Austin Bergstrom-International Airport (ABIA) on short notice, which affected numerous flights. Inbound flights on Sunday were delayed as much as two and a half hours. Travelers returning home and Central Texans meeting incoming passengers at the airport can expect more FAA-mandated delays during this busy holiday season. Best to check ahead as much as possible.

Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-Texas) released the following statement regarding President Biden’s proposal for Medicare and Medicaid to cover costly weight-loss drugs: “Big Pharma has been growing fat through price gouging—charging Americans the highest prices in the world. Instead of burdening Medicare with billions in additional costs, President Biden has the authority to reduce drug prices now for weight loss drugs and for drugs developed at taxpayer expense.

Washington, D.C.—Before Donald Trump assumes the White House and a Republican-led Congress attempts to obstruct progress on reigning in pharmaceutical companies, Representative Lloyd Doggett (D-Texas) and Senator Elizabeth Warren (D-Mass.) are urging the Biden Administration to fulfill its promise and finalize a strengthened framework to lower prescription drug prices and ensure increased transparency, oversight and accessibility of taxpayer-funded medical products. Specifically, the lawmakers ask Commerce Secretary Gina Raimondo and Health and Human Services Secretary Xavier Becerra to release the “Interagency Guidance Framework for Considering the Exercise of March-In Rights” by the end of the year.

Washington, D.C.—U.S. Representatives Lloyd Doggett (D-TX-37) and Jake Auchincloss (D-MA-4) led a bipartisan effort to demand a tightening of Russian oil sanctions and to question an exception granted to a U.S.-based company, Schlumberger (SLB). Specifically, the lawmakers are questioning Treasury Secretary Janet Yellen and Secretary Antony Blinken as to why the Biden administration has permitted SLB to serve as an accomplice to Vladimir Putin.

Washington, D.C.—Ahead of the 2025 Medicare Open Enrollment period, U.S. Representative Lloyd Doggett (D-TX-37), Ranking Member of the Ways and Means Health Subcommittee, led a bicameral group of lawmakers in urging President Biden to ensure Medicare Advantage ‘Flex Cards’ do not affect Americans’ access to federal assistance for housing, food, and more.

Washington, D.C.—Today, U.S. Representative Lloyd Doggett (D-TX-37) and U.S. Senator Elizabeth Warren (D-Mass.) led an effort to urge the Biden Administration to improve American health and well-being by lowering the cost of vital weight-loss drugs. Specifically, the members are calling for Health and Human Services (HHS) Secretary Xavier Becerra to use existing legal authority to issue generic licenses for semaglutide, a prescription drug commonly used to treat obesity and diabetes and is sold under the brand names of Ozempic and Wegovy. Similarly, a coalition of more than 20 organizations has also called on Secretary Becerra to take such action.